The good news is that most cases of whooping cough are preventable with DTaP vaccines in childhood and Tdap shots at age 11 ...

GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on ...

The U.S. Centers for Disease Control and Prevention's panel of outside experts on Wednesday recommended the use of ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new ...

The U.S. Centers for Disease Control and Prevention's outside panel of vaccine experts on Tuesday discussed narrowing ...

People are being urged to take influenza and other respiratory diseases seriously and get vaccinated before cold weather ...

Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...

of the [BioNTech] vaccine for adults for off-label use,” the body said in a statement. Fosun Pharma, distributor of the BioNTech vaccine in Hong Kong, has not applied to local authorities to ...

GSK and Pfiz­er have set­tled a law­suit al­leg­ing Pfiz­er’s RSV shot Abrys­vo in­fringed GSK’s patents.

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory uncertainties, GSK and Pfizer have decided to lay to rest their patent ...

especially in infants and older adults. The patent battle over RSV vaccines highlights intensifying competition in the global vaccine market. Despite dropping this particular case, legal tensions ...

The RSV severity for pregnant women and people appears to be similar to that for non-pregnant women and people. The RSV vaccine landscape has evolved. Previously, only one passive immunization product ...